We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+3.89%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
AUM
$322M
AUM Growth
+$9.28M
Cap. Flow
+$1.33M
Cap. Flow %
0.41%
Top 10 Hldgs %
24.44%
Holding
184
New
17
Increased
42
Reduced
59
Closed
13

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$6.21M
2
ACN icon
Accenture
ACN
+$5.86M
3
LH icon
Labcorp
LH
+$5.52M
4
EA icon
Electronic Arts
EA
+$5.12M
5
LRCX icon
Lam Research
LRCX
+$4.42M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$7.03M
2
KR icon
Kroger
KR
+$5M
3
MHK icon
Mohawk Industries
MHK
+$4.88M
4
SLB icon
SLB Ltd
SLB
+$3.51M
5
MPC icon
Marathon Petroleum
MPC
+$3.5M

Sector Composition

Rank Sector Weight
1 Healthcare 25.09%
2 Technology 14.53%
3 Industrials 11.48%
4 Communication Services 9.95%
5 Consumer Discretionary 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$635B
$9.85M 3.06%
83,395
+1,045
+1% +$127K
HD icon
2
Home Depot
HD
$332B
$8.54M 2.65%
66,403
-220
-0.3% -$29.3K
XOM icon
3
ExxonMobil
XOM
$651B
$8.44M 2.62%
96,750
-175
-0.2% -$15.5K
AAPL icon
4
Apple
AAPL
$4.89T
$7.96M 2.47%
281,692
+2,288
+0.8% +$60.6K
EW icon
5
Edwards Lifesciences
EW
$47.6B
$7.71M 2.39%
191,727
+900
+0.5% +$33.9K
META icon
6
Meta Platforms (Facebook)
META
$1.51T
$7.42M 2.3%
57,835
-135
-0.2% -$16.8K
STZ icon
7
Constellation Brands
STZ
$22.2B
$7.4M 2.3%
44,460
MSFT icon
8
Microsoft
MSFT
$2.84T
$7.28M 2.26%
126,424
-201
-0.2% -$11.3K
AVGO icon
9
Broadcom
AVGO
$1.82T
$7.17M 2.22%
415,550
+2,750
+0.7% +$46K
TMO icon
10
Thermo Fisher Scientific
TMO
$211B
$7M 2.17%
44,010
+400
+0.9% +$61.6K
LMT icon
11
Lockheed Martin
LMT
$134B
$6.73M 2.09%
28,056
+160
+0.6% +$40K
SYK icon
12
Stryker
SYK
$127B
$6.65M 2.06%
57,103
+580
+1% +$67.6K
GE icon
13
GE Aerospace
GE
$367B
$6.59M 2.04%
46,409
+224
+0.5% +$33.4K
TFX icon
14
Teleflex
TFX
$5.85B
$6.43M 2%
38,275
-470
-1% -$84.2K
ADBE icon
15
Adobe
ADBE
$89.5B
$6.37M 1.98%
58,685
+290
+0.5% +$29.1K
ACN icon
16
Accenture
ACN
$89.9B
$6.28M 1.95%
+51,435
New +$5.86M
AMGN icon
17
Amgen
AMGN
$203B
$6.12M 1.9%
+36,700
New +$6.21M
DPZ icon
18
Domino's
DPZ
$11B
$6.05M 1.88%
39,875
-165
-0.4% -$24.1K
EMR icon
19
Emerson Electric
EMR
$82.9B
$5.99M 1.86%
109,823
+1,820
+2% +$97.5K
GOOG icon
20
Alphabet (Google) Class C
GOOG
$3.9T
$5.58M 1.73%
143,620
+2,520
+2% +$95.7K
LH icon
21
Labcorp
LH
$24.3B
$5.53M 1.72%
+46,831
New +$5.52M
EA icon
22
Electronic Arts
EA
$52.4B
$5.47M 1.7%
+64,040
New +$5.12M
ABBV icon
23
AbbVie
ABBV
$458B
$4.82M 1.5%
76,431
+113
+0.1% +$7.32K
DHR icon
24
Danaher
DHR
$135B
$4.75M 1.47%
68,276
-19,496
-22% -$1.38M
LRCX icon
25
Lam Research
LRCX
$382B
$4.6M 1.43%
+485,700
New +$4.42M

Similar funds

Dixon Hubard Feinour & Brown's Q3 2016 Portfolio in Review

As of Q3 2016, Dixon Hubard Feinour & Brown held 184 positions worth $322M, up 3% from $313M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Dixon Hubard Feinour & Brown's Q3 2016 filing shows 17 new, 42 increased, 59 reduced and 13 closed positions. Its largest new stake was Amgen: 36,700 shares worth $6.12M. The largest sale was CVS Health, an estimated $7.03M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

  • Dixon Hubard Feinour & Brown's largest Q3 2016 buy was Amgen: 36,700 shares worth $6.12M.
  • Dixon Hubard Feinour & Brown added most to Travelers Companies in Q3 2016, an estimated $821K increase.
  • Dixon Hubard Feinour & Brown's biggest Q3 2016 reduction was SLB Ltd, cutting an estimated $3.51M.
  • Dixon Hubard Feinour & Brown fully exited CVS Health in Q3 2016, selling an estimated $7.03M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 24% of its $322M portfolio in Q3 2016.
  • Dixon Hubard Feinour & Brown opened 17 new positions and closed 13 in Q3 2016.
  • Dixon Hubard Feinour & Brown's portfolio value rose 3% quarter-over-quarter to $322M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q3 2016, filed 9 Nov 2016.